Compare APTV & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APTV | HOLX |
|---|---|---|
| Founded | 2011 | 1985 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5B | 16.6B |
| IPO Year | 2011 | 1995 |
| Metric | APTV | HOLX |
|---|---|---|
| Price | $72.57 | $75.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 13 |
| Target Price | ★ $96.00 | $77.89 |
| AVG Volume (30 Days) | 1.7M | ★ 2.2M |
| Earning Date | 05-04-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.75 | ★ 0.79 |
| Revenue | ★ $20,398,000,000.00 | $4,100,500,000.00 |
| Revenue This Year | $7.33 | $4.74 |
| Revenue Next Year | $4.84 | $5.03 |
| P/E Ratio | $96.77 | ★ $95.82 |
| Revenue Growth | ★ 3.47 | 1.74 |
| 52 Week Low | $47.19 | $51.90 |
| 52 Week High | $88.93 | $75.74 |
| Indicator | APTV | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 38.00 | 66.77 |
| Support Level | $65.78 | $74.53 |
| Resistance Level | $87.98 | N/A |
| Average True Range (ATR) | 2.54 | 0.23 |
| MACD | -0.83 | 0.04 |
| Stochastic Oscillator | 20.75 | 92.38 |
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.